Heilongjiang ZBD Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 3,138.19 million compared to CNY 4,214.15 million a year ago. Net income was CNY 472.74 million compared to CNY 185.44 million a year ago.

Basic earnings per share from continuing operations was CNY 0.5032 compared to CNY 0.197 a year ago. Diluted earnings per share from continuing operations was CNY 0.5029 compared to CNY 0.197 a year ago.